Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Joint Nations Programme on HIV/AIDS

- PMLiVE

Russia submits COVID-19 vaccine to WHO for emergency use listing

Russia became first country to grant approval to a COVID-19 vaccine in August

China flag thumb

Experimental Chinese COVID-19 vaccine is safe, according to researchers

Safety data was published on pre-print server medRxiv

- PMLiVE

WHO’s director-general says COVID-19 vaccine may be available by year-end

Remarks were made at a WHO executive board meeting earlier this week

- PMLiVE

Widespread COVID-19 vaccinations not expected until mid-2021, says WHO

Potential candidates must prove robust efficacy and safety first

EU flag

EU to contribute €400m to WHO’s COVID-19 vaccine facility

Contribution will go towards ensuring equitable access to COVID-19 vaccines

- PMLiVE

EU aims to vaccinate 40% of population in initial COVID-19 blueprint

Target is double the goal set by the World Health Organization

- PMLiVE

Vaccine nationalism must be prevented, says WHO director-general

Tedros Adhanom Ghebreyesus warns against supply nationalism

- PMLiVE

IFPMA launches AMR Action Fund to tackle antimicrobial resistance

Pharma and health organisations unite to address public health threat

- PMLiVE

WHO takes stock of global COVID-19 R&D progress

Researchers and developers meet virtually to discuss progress

- PMLiVE

Potential universal flu vaccine shows efficacy in clinical trial

Candidate will now move forward into late-stage testing

- PMLiVE

WHO labels coronavirus outbreak a pandemic as cases spread globally

WHO director-general maintains countries can still "change the course" of the outbreak

- PMLiVE

As new coronavirus outbreaks emerge, fears of a global pandemic escalate

Increased quarantine measures are reported across the globe

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links